Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
London, UK – Tuesday 27 September, 2022 - The 2022 Global Generics and Biosimilars Awards finalists have been announced for the annual event, taking place on 2 November, 2022 at the Frankfurt Marriott Hotel, Germany.
The Global Generics and Biosimilars Awards celebrate the greatest achievements across the development, authorisation, marketing and distribution of global off-patent pharmaceuticals. Co-locating with CPhI Worldwide in Frankfurt, these illustrious awards provide a unique opportunity for the industry to come together to discuss future opportunities and challenges and shine a light on the companies and individuals driving positive change. Winners will be recognised across 14 categories, including Biosimilar Initiative of the Year, Leader of the Year, API Supplier of the Year and Business Development of the Year.
View the shortlist here: pharmaintelligence.informa.com/ggbAwards2022
David Wallace, Executive Editor, Generics Bulletin, said “This year saw a very high quality of entries and we’re elated to announce the Global Generics and Biosimilars Awards finalists for 2022. The judging panel was extremely impressed with the achievements entered this year, which is reflected in our fantastic shortlist. I’d also like to take this opportunity to thank the judges for volunteering their time, a huge thanks to all those that entered and congratulations to all this year’s finalists. We look forward to celebrating the ongoing efforts made by the off-patent pharmaceutical industry in just over a month’s time.”
About Citeline, formerly Pharma Intelligence
Citeline (formerly Pharma Intelligence) powers a full suite of complementary business intelligence offerings to meet the evolving needs of health science professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial and regulatory related-decisions and create real-world opportunities for growth. Our global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts and more. For more information on one of the world’s most trusted health science partners, visit www.citeline.com/comingsoon
About the Global Generics and Biosimilars Awards
The Global Generics & Biosimilars Awards is the one night of the year when the off-patent pharmaceutical industry’s greatest achievements are put in the spotlight.
Taking place 2 November, 2022 at the Frankfurt Marriott Hotel, Germany, the Global Generics & Biosimilars Awards 2022 recognises companies across the off-patent industry, including small-molecule generics, biosimilars and value-added medicines, by celebrating their successes over the past year.
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Contact us for product technical and account support.
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: